Applied Biology, Inc.
Clinical trials sponsored by Applied Biology, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New scalp treatment for hair loss under study Results expected Oct 2026 (estimated)
- New drug aims to stop chemo hair loss in its tracks Results expected Feb 2027 (estimated)
- New DA-001 hair loss treatment heads to Large-Scale trial Results expected Mar 2027 (estimated)
- Can a cream turn back the clock on grey hair? new trial begins Results expected Jun 2027 (estimated)
-
New DA-001 hair loss treatment heads to Large-Scale trial
Disease control Not yet recruitingThis study tests whether a treatment called DA-001 can safely reduce hair shedding and promote regrowth in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1,120 adults will apply the treatment as directed and be monit…
Phase 2/3 • Sponsor: Applied Biology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Can a cream turn back the clock on grey hair? new trial begins
Symptom relief Not yet recruitingThis early-stage trial tests a topical cream called CS-002, which blocks a protein called mTOR, to see if it can safely reverse grey hair. One hundred adults aged 30 to 65 with grey hair will apply the cream or a placebo for several weeks. Researchers will measure changes in grey…
Phase 1/2 • Sponsor: Applied Biology, Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 16:27 UTC
-
New scalp treatment for hair loss under study
Knowledge-focused Not yet recruitingThis early-stage study tests a drug called DA-020 in 60 healthy women aged 18-55. The goal is to measure how much of the drug enters the blood after one application to the scalp and to check for side effects like blood pressure changes. This research helps understand the drug's s…
Early phase 1 • Sponsor: Applied Biology, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC